Patent US2652340A successfully refreshed from Google Patents.
Patent US4377592A successfully refreshed from Google Patents.
US4377592A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Antiarrhythmic activity of cetiedil
Assignee: Laboratoires Innothera SAS
•
Filing: 1979-10-23
•
Granted: 1983-03-22
•
Expires: 1999-10-23
Abstract
Abstract New method for treating cardiac arrhythmia by administering cetiedil to a patient.
Inventors
- 👤 Michel E. M. Aurousseau
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 19:42
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/38
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
30 words
A method for treating a patient for cardiac arrhythmia which comprises administering to the said patient a therapeutically effective dose of cetiedil, the mode of administration being oral or injection.
Claim 2
Independent Claim
30 words
A method for treating a patient for cardiac arrhythmia which comprises administering to the said patient a therapeutically effective dose of cetiedil, the mode of administration being oral or injection.
Claim 3
Dependent Claim
16 words
A method of claim 1 in which the oral dosage unit is 50 to 150 mg.
Claim 4
Dependent Claim
17 words
A method of claim 1 in which the injected dosage unit is from 5 to 50 mg.
References Cited (Backward Citations)
GB1384022A
Cited
GB1392671A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-03-21 | 1986-09-20 | 1987-03-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-03-21 | 1990-09-20 | 1991-03-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-03-21 | 1994-09-20 | 1995-03-22 | $7700.00 | Window Closed / Lapsed |